Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity - PubMed (original) (raw)
Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity
M K Brawer et al. Cancer. 1994.
Abstract
Background: Prostate adenocarcinoma is a significant cause of morbidity and mortality in older men. However, the histologic prevalence far exceeds clinically manifest disease. Increased screening has resulted in the detection of a large number of carcinomas of unknown malignant potential. The authors investigated tumor angiogenesis to predict pathologic stage in prostatic tumors. Angiogenesis in prostatic intraepithelial neoplasia (PIN), a putative premalignant lesion, also was investigated.
Methods: Immunohistochemistry was used to highlight the tumor vasculature. Vessels were quantified using computerized image analysis. A minimum of five randomly selected microscopic fields were measured from each tumor. To investigate PIN, the authors measured vessels per millimeter of gland perimeter, compared with benign glands in the same patient.
Results: Vessel density (vessels per millimeter squared [vv/mm2]) correlated with pathologic stage. The mean vessel density of organ-confined tumors was 80.2 vv/mm2 (95% confidence interval [CI], 71.4-91.0), compared with 110.4 vv/mm2 (95% CI, 97.9-122.8) for tumors with capsular penetration or positive lymph nodes. Logistic regression analysis and modeling showed vessel density superior to histologic grade and preoperative prostate-specific antigen (PSA) level in distinguishing organ-confined tumors from those having extracapsular extension or pelvic lymph node metastasis. PIN in acini and ductules had increased microvascularity relative to benign epithelium in 18 of 25 tumors (P < 0.05).
Conclusions: Neovascularity has been demonstrated to be a prerequisite for tumor progression. These data demonstrate that microvessel density in prostatic carcinoma is an independent predictor of pathologic stage and, presumably, malignant potential. Quantification of tumor angiogenesis may allow stratification of patients to type of treatment and may allow selection of expectant management for men with low tumor microvessel density.
Similar articles
- CD34 immunohistochemical assessment of angiogenesis as a prognostic marker for prostate cancer recurrence after radical prostatectomy.
Bettencourt MC, Bauer JJ, Sesterhenn IA, Connelly RR, Moul JW. Bettencourt MC, et al. J Urol. 1998 Aug;160(2):459-65. J Urol. 1998. PMID: 9679898 - Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.
Silberman MA, Partin AW, Veltri RW, Epstein JI. Silberman MA, et al. Cancer. 1997 Feb 15;79(4):772-9. doi: 10.1002/(sici)1097-0142(19970215)79:4<772::aid-cncr14>3.0.co;2-x. Cancer. 1997. PMID: 9024715 - Topography of neovascularity in human prostate carcinoma.
Siegal JA, Yu E, Brawer MK. Siegal JA, et al. Cancer. 1995 May 15;75(10):2545-51. doi: 10.1002/1097-0142(19950515)75:10<2545::aid-cncr2820751022>3.0.co;2-x. Cancer. 1995. PMID: 7537624 - Angiogenesis imaging in the management of prostate cancer.
Padhani AR, Harvey CJ, Cosgrove DO. Padhani AR, et al. Nat Clin Pract Urol. 2005 Dec;2(12):596-607. doi: 10.1038/ncpuro0356. Nat Clin Pract Urol. 2005. PMID: 16474547 Review.
Cited by
- AZGP1 deficiency promotes angiogenesis in prostate cancer.
Wen RM, Qiu Z, Marti GEW, Peterson EE, Marques FJG, Bermudez A, Wei Y, Nolley R, Lam N, Polasko AL, Chiu CL, Zhang D, Cho S, Karageorgos GM, McDonough E, Chadwick C, Ginty F, Jung KJ, Machiraju R, Mallick P, Crowley L, Pollack JR, Zhao H, Pitteri SJ, Brooks JD. Wen RM, et al. J Transl Med. 2024 Apr 24;22(1):383. doi: 10.1186/s12967-024-05183-x. J Transl Med. 2024. PMID: 38659028 Free PMC article. - Immunohistochemical Assessment of Microvessel Density in OSCC: Spatial Heterogeneity of Angiogenesis and Its Impact on Survival.
Mamilos A, Lein A, Winter L, Haas M, Reichert TE, Ettl T, Künzel J, Spanier G, Brochhausen C. Mamilos A, et al. Biomedicines. 2023 Oct 8;11(10):2724. doi: 10.3390/biomedicines11102724. Biomedicines. 2023. PMID: 37893098 Free PMC article. - Interplay between Prostate Cancer and Adipose Microenvironment: A Complex and Flexible Scenario.
Cancel M, Pouillot W, Mahéo K, Fontaine A, Crottès D, Fromont G. Cancel M, et al. Int J Mol Sci. 2022 Sep 15;23(18):10762. doi: 10.3390/ijms231810762. Int J Mol Sci. 2022. PMID: 36142673 Free PMC article. Review. - The role of androgen receptors in vascular and cell proliferation of the prostate adenocarcinomas.
Pănuş A, Mărgăritescu C, Drăgoescu PO, Tomescu PI, Ştefănescu ML, Stepan AE. Pănuş A, et al. Rom J Morphol Embryol. 2020 Jul-Sep;61(3):803-811. doi: 10.47162/RJME.61.3.18. Rom J Morphol Embryol. 2020. PMID: 33817721 Free PMC article. - Biparametric (bp) and multiparametric (mp) magnetic resonance imaging (MRI) approach to prostate cancer disease: a narrative review of current debate on dynamic contrast enhancement.
Palumbo P, Manetta R, Izzo A, Bruno F, Arrigoni F, De Filippo M, Splendiani A, Di Cesare E, Masciocchi C, Barile A. Palumbo P, et al. Gland Surg. 2020 Dec;9(6):2235-2247. doi: 10.21037/gs-20-547. Gland Surg. 2020. PMID: 33447576 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Other Literature Sources
Medical
Research Materials
Miscellaneous